AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
Related Experiment Video
Updated: Nov 23, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Ying Wang1, Zhiwen Liu1, Shaoqun Shu1
1Department of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, China.
Abstract:
Autophagy is a conserved, multistep pathway that degrades and recycles dysfunctional organelles and macromolecules to maintain cellular homeostasis. Mammalian target of rapamycin (mTOR) and adenosine-monophosphate activated-protein kinase (AMPK) are major negative and positive regulators of autophagy, respectively. In cisplatin-induced acute kidney injury (AKI) or nephrotoxicity, autophagy is rapidly induced in renal tubular epithelial cells and acts as a cytoprotective mechanism for cell survival. Both mTOR and AMPK have been implicated in the regulation of autophagy in cisplatin-induced AKI. Targeting mTOR and/or AMPK may offer effective strategies for kidney protection during cisplatin-mediated chemotherapy.
Insights
Autophagy protects kidney cells from cisplatin damage by clearing cellular waste. Targeting key regulators, mammalian target of rapamycin (mTOR) and adenosine-monophosphate activated-protein kinase (AMPK), may prevent acute kidney injury.
Area of Science:
- Cellular Biology
- Renal Physiology
- Molecular Medicine
Background:
- Autophagy is a vital cellular process for maintaining homeostasis by degrading and recycling damaged components.
- Mammalian target of rapamycin (mTOR) and adenosine-monophosphate activated-protein kinase (AMPK) are critical regulators of autophagy.
- Cisplatin chemotherapy can induce acute kidney injury (AKI), a significant clinical concern.
Purpose of the Study:
- To investigate the role of autophagy in cisplatin-induced AKI.
- To explore the involvement of mTOR and AMPK in regulating autophagy during AKI.
- To assess the potential of targeting mTOR and AMPK for kidney protection in AKI.
Main Methods:
- Utilized models of cisplatin-induced AKI.
- Examined autophagy induction in renal tubular epithelial cells.
- Assessed the activity and role of mTOR and AMPK signaling pathways.
Main Results:
- Autophagy is rapidly induced in renal tubular epithelial cells following cisplatin exposure.
- Both mTOR and AMPK play significant roles in modulating autophagy during cisplatin-induced AKI.
- The modulation of autophagy via mTOR and AMPK pathways is linked to cell survival in AKI.
Conclusions:
- Autophagy acts as a cytoprotective mechanism against cisplatin-induced nephrotoxicity.
- mTOR and AMPK are key regulators of this protective autophagy in AKI.
- Targeting mTOR and/or AMPK presents a promising therapeutic strategy for preventing cisplatin-mediated kidney damage.
More Related Videos
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology